Congress Wealth Management LLC DE decreased its stake in Morgan Stanley (NYSE:MS – Free Report) by 13.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,361 shares of the financial services provider’s stock after selling 4,258 shares during the period. Congress Wealth Management LLC DE’s holdings in Morgan Stanley were worth $3,440,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Franklin Resources Inc. lifted its stake in shares of Morgan Stanley by 75.2% in the 3rd quarter. Franklin Resources Inc. now owns 7,850,848 shares of the financial services provider’s stock valued at $881,493,000 after acquiring an additional 3,369,520 shares during the last quarter. Raymond James Financial Inc. bought a new position in Morgan Stanley in the fourth quarter valued at about $324,118,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of Morgan Stanley by 382.4% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,597,800 shares of the financial services provider’s stock valued at $166,555,000 after purchasing an additional 1,266,600 shares in the last quarter. American Century Companies Inc. grew its holdings in shares of Morgan Stanley by 111.7% during the fourth quarter. American Century Companies Inc. now owns 2,331,960 shares of the financial services provider’s stock worth $293,174,000 after purchasing an additional 1,230,623 shares during the last quarter. Finally, Proficio Capital Partners LLC increased its stake in shares of Morgan Stanley by 26,142.5% in the fourth quarter. Proficio Capital Partners LLC now owns 1,055,210 shares of the financial services provider’s stock valued at $132,661,000 after buying an additional 1,051,189 shares during the period. Institutional investors and hedge funds own 84.19% of the company’s stock.
Morgan Stanley Price Performance
Shares of NYSE MS opened at $122.17 on Thursday. The firm has a market capitalization of $197.05 billion, a P/E ratio of 15.39, a P/E/G ratio of 1.18 and a beta of 1.35. The firm’s 50-day moving average price is $130.39 and its 200-day moving average price is $123.50. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 3.14. Morgan Stanley has a 1-year low of $85.01 and a 1-year high of $142.03.
Morgan Stanley Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Friday, January 31st were paid a dividend of $0.925 per share. The ex-dividend date of this dividend was Friday, January 31st. This represents a $3.70 dividend on an annualized basis and a yield of 3.03%. Morgan Stanley’s dividend payout ratio (DPR) is presently 46.60%.
Insiders Place Their Bets
In other news, insider Eric F. Grossman sold 13,097 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $136.20, for a total value of $1,783,811.40. Following the completion of the sale, the insider now directly owns 197,444 shares of the company’s stock, valued at $26,891,872.80. This represents a 6.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Raja Akram sold 17,500 shares of Morgan Stanley stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $136.01, for a total value of $2,380,175.00. Following the transaction, the chief financial officer now directly owns 81,440 shares in the company, valued at approximately $11,076,654.40. The trade was a 17.69 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.24% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on the stock. JPMorgan Chase & Co. lifted their target price on shares of Morgan Stanley from $124.00 to $129.00 and gave the stock a “neutral” rating in a research report on Tuesday. The Goldman Sachs Group cut their price target on shares of Morgan Stanley from $144.00 to $126.00 and set a “neutral” rating on the stock in a report on Wednesday, March 19th. Evercore ISI increased their price objective on Morgan Stanley from $140.00 to $150.00 and gave the company an “outperform” rating in a report on Friday, January 17th. Keefe, Bruyette & Woods lifted their target price on Morgan Stanley from $138.00 to $145.00 and gave the stock a “market perform” rating in a report on Friday, January 17th. Finally, Erste Group Bank cut Morgan Stanley from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Twelve analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $132.33.
Check Out Our Latest Stock Report on MS
Morgan Stanley Profile
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Featured Articles
- Five stocks we like better than Morgan Stanley
- 3 Stocks to Consider Buying in October
- Energy Transfer: Powering Data With Dividends and Diversification
- 3 Fintech Stocks With Good 2021 Prospects
- Qualcomm Stock Is Coiling for a Breakout
- How to buy stock: A step-by-step guide for beginners
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.